Matthew S McIlwain insider trades

Open-market stock purchases and sales by Matthew S McIlwain, Director at Nautilus Biotechnology, Inc, from SEC Form 4 filings since Apr 26, 2010.

Track record: 0% of 4 scored buys are up 5% or more since purchase, averaging -65%.

Recent trades

DateStockTradeValue
Jun 18, 2026NAUT Nautilus Biotechnology, IncBought (not open market)—

Companies traded

  • NAUT Nautilus Biotechnology, Inc: 4 buys, last Jun 18, 2026
  • SMAR Smartsheet Inc: 4 buys, 47 sales, last Jan 22, 2025
  • APTI Apptio Inc: 10 sales, last Jan 10, 2019
  • ISLN Isilon Systems, Inc: 4 sales, last Dec 17, 2010

Get free alerts when Matthew S McIlwain files a new trade →